doxycycline
pfizer
['dynamic study', 'dynamic']
more data presented by at #esmo2022 in "ctdna dynamics, cea and sites of recurrence for the randomised dynamic study" : ctdna clearance by end of chemo predicts recurrence free survival 
Registry and translational (ctDNA, organoid) research in solid organ cancers in @WEHI_research led by Peter Gibbs | https://t.co/WXeH9Tec60… | Views our own